Ramelteon for prevention of delirium in hospitalized older patients

JAMA - Journal of the American Medical Association

Volumn 313, Issue 17, 2015, Pages 1745-1746

  Perkisas, Stany M T ^a   Vandewoude, Maurits F J ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RAMELTEON; INDENE DERIVATIVE;

AGED; COHORT ANALYSIS; DELIRIUM; DISEASE ASSOCIATION; HOSPITAL PATIENT; HUMAN; INCIDENCE; MULTICENTER STUDY (TOPIC); PATIENT RISK; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SHORT SURVEY; FEMALE; MALE;

DELIRIUM; FEMALE; HUMANS; INDENES; MALE;

EID: 84929051897     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.17394     Document Type: Short Survey

References (6)

1. Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Lancet. 2014;383(9920):911-922.
2. Gareri P, De Fazio P, Manfredi VG, De Sarro G. Use and safety of antipsychotics in behavioral disorders in elderly people with dementia. J Clin Psychopharmacol. 2014;34(1):109-123.
3. Langballe EM, Engdahl B, Nordeng H, Ballard C, Aarsland D, Selbæk G. Short- and long-term mortality risk associated with the use of antipsychotics among 26,940 dementia outpatients: a population-based study. Am J Geriatr Psychiatry. 2014;22(4):321-331.
4. Howland RH. Delirium and its prevention with melatonergic drugs. J Psychosoc Nurs Ment Health Serv. 2014;52(5):13-16.
5. Hatta K, Kishi Y,Wada K, et al. Preventive effects of ramelteon on delirium: a randomized placebo-controlled trial. JAMA Psychiatry. 2014;71(4):397-403.
6. Al-Aama T, Brymer C, Gutmanis I, Woolmore-Goodwin SM, Esbaugh J, Dasgupta M. Melatonin decreases delirium in elderly patients: a randomized, placebo-controlled trial. Int J Geriatr Psychiatry. 2011;26(7):687-694.